American Cancer Society Report Highlights Declining Mortality Rates But Rising Cancer Incidence Among Women
The American Cancer Society (ACS) recently published its annual report, "Cancer Statistics, 2025," which highlights both promising and troubling trends in cancer data across the United States. While the overall cancer mortality rate has significantly declined – by 34% from 1991 to 2022, resulting in approximately 4.5 million lives saved – there is growing concern regarding the rising incidence of several cancers, particularly among women and younger adults.
The report reveals that the incidence rates of cancer in women aged 50 to 64 have now surpassed those seen in men of the same age group. Nonetheless, the most striking increase is found among women under 50, whose incidence rates are 82% higher than their male counterparts. This marks a drastic jump from just 51% in 2002. Notably, even lung cancer rates have seen a significant shift, with women under 65 now being diagnosed at higher rates than men.
Rebecca Siegel, the senior scientific director of surveillance research at ACS, remarked, "The progress we see in reducing cancer mortality is overshadowed by the rising incidence in young and middle-aged women, which reflects a historical shift in cancer's burden from men to women."
The report predicts that in 2025 there will be an estimated 2,041,910 new cancer diagnoses in the U.S., translating to an alarming 5,600 new cases each day. Additionally, the mortality estimates indicate approximately 618,120 deaths due to cancer this year. These statistics are derived from the latest population-based data collected from cancer registries and mortality records.
One area of particular concern is pancreatic cancer, which continues to lag in treatment advancements. Not only is it the third leading cause of cancer death in the U.S., but both the incidence and mortality rates are also rising, with a dismal five-year survival rate of just 8% for the vast majority of those diagnosed with pancreatic exocrine tumors.
Dr. William Dahut, ACS's chief scientific officer, emphasized the organization's commitment to improving outcomes through research and funding, stating, "As the largest nonprofit funding source for cancer research in the U.S., we are currently investing over $450 million in grants to drive innovation and discovery in cancer treatments."
Despite the overall decline in cancer mortality rates, the report underscores persistent inequalities in cancer outcomes. The mortality rates of Native American individuals are two to three times higher compared to their White counterparts for various cancers, including kidney and liver cancers. Additionally, Black individuals are at a greater risk of dying from prostate and cervical cancers, amongst others.
"Our battle against cancer has been hampered by disparities that affect certain racial and ethnic groups significantly," said Dr. Ahmedin Jemal, a senior vice president at ACS. He called attention to the urgent need for equitable care across all demographics to address these ongoing needs effectively.
The ACS report calls for increased investment in cancer treatment and equitable screening programs. Dr. Wayne A. I. Frederick, interim CEO of the American Cancer Society, advocates for a stronger collaborative effort among healthcare providers, policymakers, and communities to effectively tackle cancer and reduce incidence rates among women.
As we move forward, the pressing call for enhanced resources, research, and awareness surrounding cancer, particularly among the most vulnerable populations, remains vital in the fight to end cancer as we know it. The ACS remains dedicated to this vision and encourages everyone to partake in promoting better health outcomes and early detection strategies.
For individuals seeking support and information about cancer or treatment options, ACS provides numerous resources at their website and a helpline available 24/7.
Key Findings
The report reveals that the incidence rates of cancer in women aged 50 to 64 have now surpassed those seen in men of the same age group. Nonetheless, the most striking increase is found among women under 50, whose incidence rates are 82% higher than their male counterparts. This marks a drastic jump from just 51% in 2002. Notably, even lung cancer rates have seen a significant shift, with women under 65 now being diagnosed at higher rates than men.
Rebecca Siegel, the senior scientific director of surveillance research at ACS, remarked, "The progress we see in reducing cancer mortality is overshadowed by the rising incidence in young and middle-aged women, which reflects a historical shift in cancer's burden from men to women."
The report predicts that in 2025 there will be an estimated 2,041,910 new cancer diagnoses in the U.S., translating to an alarming 5,600 new cases each day. Additionally, the mortality estimates indicate approximately 618,120 deaths due to cancer this year. These statistics are derived from the latest population-based data collected from cancer registries and mortality records.
Challenges with Specific Cancers
One area of particular concern is pancreatic cancer, which continues to lag in treatment advancements. Not only is it the third leading cause of cancer death in the U.S., but both the incidence and mortality rates are also rising, with a dismal five-year survival rate of just 8% for the vast majority of those diagnosed with pancreatic exocrine tumors.
Dr. William Dahut, ACS's chief scientific officer, emphasized the organization's commitment to improving outcomes through research and funding, stating, "As the largest nonprofit funding source for cancer research in the U.S., we are currently investing over $450 million in grants to drive innovation and discovery in cancer treatments."
Disparities and Inequities
Despite the overall decline in cancer mortality rates, the report underscores persistent inequalities in cancer outcomes. The mortality rates of Native American individuals are two to three times higher compared to their White counterparts for various cancers, including kidney and liver cancers. Additionally, Black individuals are at a greater risk of dying from prostate and cervical cancers, amongst others.
"Our battle against cancer has been hampered by disparities that affect certain racial and ethnic groups significantly," said Dr. Ahmedin Jemal, a senior vice president at ACS. He called attention to the urgent need for equitable care across all demographics to address these ongoing needs effectively.
Looking Ahead
The ACS report calls for increased investment in cancer treatment and equitable screening programs. Dr. Wayne A. I. Frederick, interim CEO of the American Cancer Society, advocates for a stronger collaborative effort among healthcare providers, policymakers, and communities to effectively tackle cancer and reduce incidence rates among women.
As we move forward, the pressing call for enhanced resources, research, and awareness surrounding cancer, particularly among the most vulnerable populations, remains vital in the fight to end cancer as we know it. The ACS remains dedicated to this vision and encourages everyone to partake in promoting better health outcomes and early detection strategies.
For individuals seeking support and information about cancer or treatment options, ACS provides numerous resources at their website and a helpline available 24/7.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.